![]() |
|
RESÚMENES DICIEMBRE 2004 |
Addictive Disorders
(Requiere
estar conectado a internet. Haga un click en la información del journal)
Double-Blind
Placebo-Controlled Trial of Fluoxetine in Smoking Cessation Treatment Including
Nicotine Patch and Cognitive-Behavioral Group Therapy
Karen Saules, Leslie Schuh,
Cynthia Arfken, Karen Reed, M. Kilbey, Charles Schuster
The majority of
hospitalised patients have drug-related problems: results from a prospective
study in general hospitals
Hege Salvesen Blix,
Kirsten K. Viktil, Åsmund Reikvam, Tron Anders Moger,
Bodil Jahren Hjemaas, Piia Pretsch,
Tine Flindt Vraalsen and Elspeth K. Walseth
European Journal of Clinical Pharmacology 2004; Volume
60, Number 9: 651 - 658
Gabor
Oroszi; David Goldman
Pharmacogenomics 2004, vol. 5, no. 8, pp. 1037 - 1048
Reinforcing, subject-rated, performance and physiological effects of methylphenidate and d-amphetamine in stimulant abusing humans
William W. Stoops, Paul E.A. Glaser, Mark T. Fillmore, Craig R. Rush
Journal
of Psychopharmacology, Vol. 18, No. 4, 534-543 (2004)
A Family Study of Alcohol Dependence. Coaggregation of
Multiple Disorders in Relatives of Alcohol-Dependent Probands
John
I. Nurnberger, Jr, Ryan Wiegand, Kathleen Bucholz, Sean O’Connor, Eric T.
Meyer, Theodore Reich, John Rice, Marc Schuckit, Lucy King, Theodore Petti,
Laura Bierut, Anthony L. Hinrichs; Samuel Kuperman, Victor Hesselbrock, Bernice
Porjesz
Arch Gen Psychiatry. 2004;61:1246-1256
Association of
alcohol and drug use disorders and completed suicide: an empirical review of
cohort studies
Holly C. Wilcox,
Kenneth R. Conner and Eric D. Caine
Drug and Alcohol Dependence. Volume 76, Supplement 1,
7 December 2004, Pages S11-S19
Neurobehavior
disinhibition in childhood predicts suicide potential and substance use
disorder by young adulthood
R.E. Tarter, Levent
Kirisci, Maureen Reynolds and Ada Mezzich
Drug and Alcohol Dependence. Volume 76, Supplement 1,
7 December 2004, Pages S45-S52
Anne L. Glowinski,
Theodore Jacob, Kathleen K. Bucholz, Jeffrey F. Scherrer, William True and
Andrew C. Heath
Drug and Alcohol Dependence. Volume 76, Supplement 1,
7 December 2004, Pages S69-S77
Depressive
symptoms during buprenorphine vs. methadone maintenance: findings from a
randomised, controlled trial in opioid dependence
Angela J.
Dean, James Bell,Macdonald J. Christie and Richard P. Mattick
European Psychiatry. Volume 19, Issue 8, December
2004, Pages 510-513
Alfredo Sbrana,
Jacopo Vittoriano Bizzarri, Paola Rucci, Chiara Gonnelli, Maria Rosa Doria,
Sabrina Spagnolli, Laura Ravani, Federica Raimondi, Lilliana Dell'Osso and
Giovanni Battista Cassano
Comprehensive Psychiatry. Volume 46, Issue 1,
January-February 2005, Pages 6-13
John A. Matochik,
Dana A. Eldreth, Jean-Lud Cadet and Karen I. Bolla
Drug and Alcohol Dependence. Volume 77, Issue 1, 7
January 2005, Pages 23-30
A double-blind,
double-dummy, randomized, prospective pilot study of the partial Mu opiate
agonist, buprenorphine, for acute detoxification from heroin
Michael R.
Oreskovich, Andrew J. Saxon, Mei Ling K. Ellis, Carol A. Malte, Joseph P. Reoux
and Patricia C. Knox
Drug and Alcohol Dependence. Volume 77, Issue 1, 7
January 2005, Pages 71-79
A Double-Blind, Placebo-Controlled Trial of Modafinil for
Cocaine Dependence
Charles A Dackis, Kyle M Kampman,
Kevin G Lynch, Helen M Pettinati and Charles P O'Brien
Neuropsychopharmacology (2005) 30, 205-211
Reinforcing
effects of methylphenidate: influence of dose and behavioral demands following
drug administration
William W. Stoops,
Joshua A. Lile, Mark T. Fillmore,
Paul E. A. Glaser and Craig R. Rush
Psychopharmacology 2005;Volume 177, Number 3: 349
- 355
Morphine-induced
Changes of Gene Expression in the Brain
Susanne Ammon-Treiber and
Volker Höllt
Addiction Biology Volume 10, Number 1 / March 2005:81
- 89
Gene Expression
Profiling in the Brains of Human Cocaine Abusers
Michael J Bannon, Gregory
Kapatos, Dawn N Albertson
Addiction Biology Volume 10, Number 1 / March 2005:119
- 126